Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

标题
Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
作者
关键词
-
出版物
CLINICAL CANCER RESEARCH
Volume 17, Issue 7, Pages 1973-1983
出版商
American Association for Cancer Research (AACR)
发表日期
2011-02-25
DOI
10.1158/1078-0432.ccr-10-2011

向作者/读者发起求助以获取更多资源

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now